Rotten Tomatoes Critics And Users Are Cursing ‘The Witcher’ Season 4

The fourth season of Netflix's 'The Witcher' brings exciting developments for Geralt, Yennefer, and Ciri as they navigate significant changes and join a larger conflict. This season is crucial as it deepens character arcs and sets the stage for future storylines, keeping fans engaged and eager for more.

As Halloween approaches, horror movie enthusiasts have a reason to celebrate with a curated list of the ten best horror films according to Rotten Tomatoes. These films have received high praise from critics, making them must-watch selections for anyone looking to enjoy the spooky season. This list not only highlights the standout films but also serves as a guide for viewers seeking quality scares, ensuring that your Halloween viewing is both thrilling and satisfying.

The Witcher returns for its fourth season, now featuring Liam Hemsworth as Geralt, taking over from Henry Cavill. Critics are weighing in on this significant change, discussing the potential impact on the show's future and fan reception. This shift has sparked conversations about casting choices in popular series and how they affect audience engagement.

The recent defense by 'The Witcher' showrunner regarding a controversial line in Season 4 has raised eyebrows among fans. Many believe that the creators are straying too far from the essence of Geralt of Rivia, a character beloved for his depth and complexity. This situation matters because it highlights the ongoing tension between creative adaptation and staying true to source material, which can impact viewer loyalty and the show's overall reception.

A new Netflix show has achieved remarkable success by earning a 100% critics score on Rotten Tomatoes for its third consecutive season. This milestone not only highlights the show's quality but also sets a new standard in the industry, showcasing the ability to maintain excellence over time. Such achievements are significant as they reflect the show's popularity and critical acclaim, drawing in more viewers and potentially influencing future productions.

Emma Stone's latest film, 'Bugonia,' directed by Yorgos Lanthimos, is set for a wide release this Friday. Critics on Rotten Tomatoes have shared mixed reviews, raising questions about whether the film resonates with audiences or alienates them. This is significant as it highlights the challenges filmmakers face in balancing artistic vision with audience expectations.

Recent developments in the credit market are raising alarms for Wall Street, suggesting potential instability ahead. The metaphor of cockroaches sinking a ship highlights the concern that small issues can lead to larger problems in financial systems. This matters because it could signal a downturn in the economy, affecting investments and consumer confidence.

The Bloomberg Brief for October 31, 2025, provides a comprehensive overview of the latest developments in finance and markets. This video highlights key trends and insights that are shaping the economic landscape, making it essential for investors and analysts to stay informed. Understanding these updates can help individuals and businesses make better financial decisions.

LendInvest Secured Income II has reported an impressive £39 million in eligible loans for the third quarter of 2025. This significant figure highlights the growing confidence in the property finance market and showcases LendInvest's strong position in providing accessible funding solutions. As the demand for loans continues to rise, this achievement not only reflects the company's robust performance but also signals a positive trend for investors looking for reliable opportunities in the financial sector.

Connect Biopharma has received a Buy rating from BTIG, highlighting the company's promising potential in the respiratory drug market. This endorsement is significant as it suggests confidence in the company's innovative approaches and could attract more investors, boosting its stock performance. The focus on respiratory treatments is particularly timely given the ongoing global health challenges, making this development noteworthy for both the company and its stakeholders.

UBS has adjusted its price target for Zillow Group's stock from $95 to $92 while maintaining a 'Buy' rating. This change reflects UBS's analysis of the current market conditions and Zillow's performance. Investors should note that despite the lowered target, the 'Buy' rating suggests confidence in Zillow's long-term potential.

AppLovin's stock price target has been lowered to $664 by BTIG, reflecting mixed feedback from analysts. This adjustment highlights concerns about the company's performance and market perception, which could impact investor confidence and future growth prospects.